Ignite Creation Date:
2024-05-06 @ 8:05 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02664181
Status:
COMPLETED
Last Update Posted:
2024-07-03
First Post:
2016-01-22
Brief Title:
Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC PRECISE Trial
Sponsor:
Organization:
Case Comprehensive Cancer Center